References
1. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 2010;137:263-72.
2. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012; 33:1500
3. Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013 May 30;368:2113-24. doi: 10.1056/NEJMra1206531.
4. Kleiman NS. Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation. Circulation 2012;125:1967-70.
5. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:2 Suppl:e419S-e494S. [Erratum, Chest 2012; 142:1698-1704.]
6. ASGE Standards of Practice Committee, Anderson MA, Ben-Menachem T, Gan SI, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009;70:1060-70.
7. Boustière C, Veitch A, Vanbiervliet G, et al, European Society of Gastrointestinal Endoscopy. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2011;43:445-61.
8. Andreu García M,. Manejo de la anticoagulación en la endoscopia terapéutica. GH continuada 2010; 9: 302-5.
9. Sierra P, Gómez-Luque A, Castillo J, et al. Guía de práctica clínica sobre el manejo perioperatorio de antiagregantes plaquetarios en cirugía no cardiaca (Sociedad Española de Anestesiología y Reanimación). Rev Esp Anestesiol Reanim. 2011; 58 (Suppl 1):1-16.
10. Baron TH, Kamath PS, McBane RD. New anticoagulant and antiplatelet agents: a primer for the gastroenterologist. Clin Gastroenterol Hepatol. 2014;12:187-95.
11. Douketis JD, Spyropoulos AC, Spencer FA, et al. American Collegeof Chest Physicians. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (erratum in: Chest 2012;141:1129). Chest 2012; 141(Suppl):e326S–e350S.
12. Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg 2011;112:292–318.
13. Soff GA. A new generation of oral direct anticoagulants. Arterioscler Thromb Vasc Biol 2012;32:569–74.
14. Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of and antiplatelet therapy in patients undergoing anticoagulant endoscopic procedures. Gut. 2008;57:1322-9.
15. Llau JV, Ferrandis R, Castillo J, et al. participantes en el Foro de Consenso de la ESRA-España sobre «Fármacos que alteran la hemostasia». Manejo de los anticoagulantes orales de acción directa en el periodo perioperatorio y técnicas invasivas. Rev Esp Anestesiol Reanim. 2012;59:321-30.
16. Desai J, Granger CB, Weitz JI, et al. Novel oral anticoagulants in gastroenterology practice. Gastrointest Endosc. 2013;78:227-39.
17. Connolly SJ, Ezekowitz MD, Yusuf S, et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation (erratum in: N Engl J Med
2010;363:1877). N Engl J Med 2009;361:1139–51.
18. Coleman CI, Sobieraj DM, Winkler S, et al. Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation. Int J Clin Pract 2012;66:53-63.
19. Hankey GJ, Eikelboom JW. Dabigatran etexilate: a new oral thrombin inhibitor. Circulation 2011;123:1436–50.
20. Anderson MA, Ben-Menachem T, Gan SI, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009;70:1060-70.
21. Eikelboom JW, Wallentin L, Connolly SJ, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation
2011;123:2363-72.
22. FDA Advisory Committee. Dabigatran briefing document [Boehringer Ingelheim]. Cardiovascular and Renal Drugs Advisory Committee (FDA). 2010;:1-168.
23. Peacock WF, Gearhart MM, Mills RM. Emergency management of bleeding associated with old and new oral anticoagulants. Clin Cardiol 2012;35:730–7.
24. Nessel C, Mahaffey K, Piccini J, et al. Incidence and outcomes of gastrointestinal hemorrhage in patients with atrial fibrillation treated with rivaroxaban or warfarin: results from the ROCKET AF trial. Chest J [Internet] 2012 Accessed Dec 4, 2012;142 (4_MeetingAbstracts):84A.
25. Bytzer P, Connolly SJ, Yang S, et al. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial. Clin Gastroenterol Hepatol 2013;11:246-52
26. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.
27. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-429.
28. Van Kuijk JP, Flu WJ, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol. 2009;104:1229-34. doi: 10.1016/j.amjcard.2009.06.038.
29. Kimchi NA, Broide E, Scapa E, et al. Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures. A systematic review of the literature and recommendations. Digestion. 2007;75:36-45..
30. Alberca de las Parras F, Marín F, Roldán Schilling V, et al Manejo de los fármacos antitrombóticos asociado a procedimientos endoscópicos. Rev Esp Enferm Dig 2015; 107: 289-306
31. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 2010;137:263-72
32. Gandhi S, Narula N, Mosleh W, et al. Meta-analysis: colonoscopic pst-polypectomy bleeding in patients on continued clopidogrel therapt. Aliment Pharmacol Ther 2013; 37: 947-52.
33. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding. Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270–382.